Varenicline: a novel pharmacotherapy for smoking cessation (Q37543427)

20 August 2017

1 reference

title

Varenicline: a novel pharmacotherapy for smoking cessation (English)

1 reference

20 August 2017

0 references

1 reference

Carlos Jiménez-Ruiz

1

1 reference

20 August 2017

Ivan Berlin

series ordinal

2

1 reference

20 August 2017

Thomas Hering

series ordinal

3

1 reference

20 August 2017

publication date

1 July 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

69

1 reference

20 August 2017

issue

10

1 reference

20 August 2017

page(s)

1319-1338

1 reference

Signs and symptoms of tobacco withdrawal.

20 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200969100-00003

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness

21 January 2018

1 reference

12 December 2020

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

1 reference

12 December 2020

Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis

1 reference

12 December 2020

Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline

1 reference

12 December 2020

Exacerbation of schizophrenia by varenicline

1 reference

12 December 2020

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

1 reference

12 December 2020

Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression

1 reference

12 December 2020

A preliminary benefit-risk assessment of varenicline in smoking cessation

1 reference

12 December 2020

1 reference

12 December 2020

Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies

1 reference

12 December 2020

Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings

1 reference

12 December 2020

Antidepressants for smoking cessation

1 reference

12 December 2020

Lack of pharmacokinetic and pharmacodynamic interactions between a smoking cessation therapy, varenicline, and warfarin: an in vivo and in vitro study

1 reference

12 December 2020

Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage

1 reference

12 December 2020

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

1 reference

12 December 2020

Cost effectiveness analysis of smoking cessation interventions

1 reference

12 December 2020

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

1 reference

12 December 2020

Role of dopamine in the behavioural actions of nicotine related to addiction

1 reference

12 December 2020

Clarification of SRNT workgroup guidelines for measures in clinical trials of smoking cessation therapies

1 reference

12 December 2020

Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro

1 reference

12 December 2020

Varenicline-induced manic episode in a patient with bipolar disorder

1 reference

12 December 2020

Varenicline improves mood and cognition during smoking abstinence

1 reference

12 December 2020

Nicotine receptor partial agonists for smoking cessation

1 reference

12 December 2020

Interventions for preventing weight gain after smoking cessation

1 reference

12 December 2020

Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire.

1 reference

12 December 2020

US public health service clinical practice guideline: treating tobacco use and dependence.

1 reference

12 December 2020

Cytisine for smoking cessation: a literature review and a meta-analysis

1 reference

12 December 2020

Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.

1 reference

12 December 2020

Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.

1 reference

12 December 2020

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

1 reference

12 December 2020

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

12 December 2020

Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study

1 reference

12 December 2020

Exacerbation of recurrent depression as a result of treatment with varenicline

1 reference

12 December 2020

Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors

1 reference

12 December 2020

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors

1 reference

12 December 2020

Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation

1 reference

12 December 2020

Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization

1 reference

12 December 2020

Varenicline for smoking cessation: a placebo-controlled, randomized study

1 reference

12 December 2020

Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers

1 reference

12 December 2020

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

1 reference

12 December 2020

Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers

1 reference

12 December 2020

Mortality in relation to smoking: 50 years' observations on male British doctors

1 reference

12 December 2020

Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers

1 reference

12 December 2020

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

1 reference

12 December 2020

The pharmacokinetic and tolerability profile of varenicline in healthy Chinese volunteers.

1 reference

12 December 2020

Varenicline treatment for smokers with schizophrenia: a case series.

1 reference

12 December 2020

The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial

1 reference

12 December 2020

Nicotinic receptors at the amino acid level

1 reference

12 December 2020

A double-blind study evaluating the long-term safety of varenicline for smoking cessation

1 reference

12 December 2020

Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine

1 reference

12 December 2020

A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers

1 reference

12 December 2020

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt

1 reference

12 December 2020

Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy.

1 reference

12 December 2020

Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers

1 reference

12 December 2020

Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers

1 reference

12 December 2020

Nicotine replacement therapy for smoking cessation

1 reference

12 December 2020

10.2165/00003495-200969100-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

20 August 2017

1014216757

0 references

1 reference